A previous blog post discussed an ongoing trial (Keynote-028) of a promising new treatment for mesothelioma. The study aimed to examine the effects of Keytruda, a checkpoint inhibitor immunotherapy drug, on patients with mesothelioma. The U.S. Food and Drug...
Despite its drastic reduction in use, asbestos is still claiming the lives of thousands of people each year. Prolonged exposure to the deadly mineral can result in fatal asbestos-related diseases such asbestosis, COPD and mesothelioma. These diseases affect not only...
Over four decades ago, it was established that companies were using asbestos in their products despite their knowledge of its lethal health risks. As more people began to file lawsuits and companies were unable to satisfy their financial liabilities, asbestos trust...
Thousands of people are diagnosed with mesothelioma each year. The latency period for mesothelioma is particularly long. Consequently, it has decades to establish itself in the body before disease diagnosis and treatment.Especially for people in high-risk occupations...
